Management of male obesity-related secondary hypogonadism: A clinical update

doi:10.5493/wjem.v14.i2.93689

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2253)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

HTML

1388

Figures (1-2)

213

Tables (1-2)

183

Sum=1882

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

158

Sum=206

Jun 20, 2024 (publication date) through Feb 11, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Exp Med. Jun 20, 2024; 14(2): 93689
Published online Jun 20, 2024. doi: 10.5493/wjem.v14.i2.93689

Full Size Figure Download Figure

Figure 1 The pathobiology of male obesity-related secondary hypogonadism. E: Estradiol; GnRH: Gonadotropin-releasing hormone; LH: Luteinizing hormone; T: Testosterone.

Citation: Shenoy MT, Mondal S, Fernandez CJ, Pappachan JM. Management of male obesity-related secondary hypogonadism: A clinical update. World J Exp Med 2024; 14(2): 93689
URL: https://www.wjgnet.com/2220-315x/full/v14/i2/93689.htm
DOI: https://dx.doi.org/10.5493/wjem.v14.i2.93689